{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:27:35Z","timestamp":1767713255380,"version":"3.41.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Health | National Health and Medical Research Council","award":["1159901"],"award-info":[{"award-number":["1159901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12191-4","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:18:07Z","timestamp":1753258687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain"],"prefix":"10.1038","volume":"15","author":[{"given":"Mahtab","family":"Eivazitork","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya J.","family":"Lupancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M. C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-2338","authenticated-orcid":false,"given":"Adrian A.","family":"Achuthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"6","key":"12191_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7 (6), 429\u2013442. https:\/\/doi.org\/10.1038\/nri2094 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"12191_CR2","doi-asserted-by":"publisher","first-page":"1196931","DOI":"10.3389\/fimmu.2023.1196931","volume":"14","author":"T Balendran","year":"2023","unstructured":"Balendran, T. et al. Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. Front. Immunol. 14, 1196931. https:\/\/doi.org\/10.3389\/fimmu.2023.1196931 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"12191_CR3","doi-asserted-by":"publisher","first-page":"pjem20190945","DOI":"10.1084\/jem.20190945","volume":"217","author":"JA Hamilton","year":"2020","unstructured":"Hamilton, J. A. GM-CSF in inflammation. J. Exp. Med. 217 (1), pjem20190945. https:\/\/doi.org\/10.1084\/jem.20190945 (2020).","journal-title":"J. Exp. Med."},{"key":"12191_CR4","doi-asserted-by":"publisher","first-page":"101523","DOI":"10.1016\/j.smim.2021.101523","volume":"54","author":"AA Achuthan","year":"2021","unstructured":"Achuthan, A. A. et al. Targeting GM-CSF in inflammatory and autoimmune disorders. Semin. Immunol. 54, 101523. https:\/\/doi.org\/10.1016\/j.smim.2021.101523 (2021).","journal-title":"Semin. Immunol."},{"issue":"10","key":"12191_CR5","doi-asserted-by":"publisher","first-page":"108079","DOI":"10.1016\/j.isci.2023.108079","volume":"26","author":"TJ Lupancu","year":"2023","unstructured":"Lupancu, T. J. et al. Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis. iScience. 26 (10), 108079. https:\/\/doi.org\/10.1016\/j.isci.2023.108079 (2023).","journal-title":"iScience"},{"issue":"9","key":"12191_CR6","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1172\/JCI87828","volume":"126","author":"A Achuthan","year":"2016","unstructured":"Achuthan, A. et al. Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation. J. Clin. Investig. 126 (9), 3453\u20133466. https:\/\/doi.org\/10.1172\/JCI87828 (2016).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"12191_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13075-018-1560-9","volume":"20","author":"MC Lee","year":"2018","unstructured":"Lee, M. C. et al. CCL17 Blockade as a therapy for osteoarthritis pain and disease. Arthritis Res. Ther. 20 (1), 62. https:\/\/doi.org\/10.1186\/s13075-018-1560-9 (2018).","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"12191_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.194.6.847","volume":"194","author":"A Iellem","year":"2001","unstructured":"Iellem, A. et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194 (6), 847\u2013853. https:\/\/doi.org\/10.1084\/jem.194.6.847 (2001).","journal-title":"J. Exp. Med."},{"issue":"6","key":"12191_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1084\/jem.20070081","volume":"204","author":"BD Sather","year":"2007","unstructured":"Sather, B. D. et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204 (6), 1335\u20131347. https:\/\/doi.org\/10.1084\/jem.20070081 (2007).","journal-title":"J. Exp. Med."},{"key":"12191_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molimm.2025.06.008","volume":"184","author":"S Ganeshalingam","year":"2025","unstructured":"Ganeshalingam, S. et al. Cellular interactions in maintaining an inflammatory microenvironment in rheumatoid arthritis. Mol. Immunol. 184, 112\u2013122. https:\/\/doi.org\/10.1016\/j.molimm.2025.06.008 (2025).","journal-title":"Mol. Immunol."},{"issue":"8","key":"12191_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3 (8), 673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468 (2004).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"29","key":"12191_CR12","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1074\/jbc.RA118.002416","volume":"293","author":"AT Hsu","year":"2018","unstructured":"Hsu, A. T. et al. Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages. J. Biol. Chem. 293 (29), 11415\u201311423. https:\/\/doi.org\/10.1074\/jbc.RA118.002416 (2018).","journal-title":"J. Biol. Chem."},{"key":"12191_CR13","doi-asserted-by":"publisher","unstructured":"Monaghan, K. L. et al. Tetramerization of STAT5 promotes autoimmune-mediated neuroinflammation. Proc. Natl. Acad. Sci. U. S. A. 118 (52). https:\/\/doi.org\/10.1073\/pnas.2116256118 (2021).","DOI":"10.1073\/pnas.2116256118"},{"issue":"10","key":"12191_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","volume":"145","author":"G Feng","year":"2022","unstructured":"Feng, G. et al. CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells. Circulation. 145 (10), 765\u2013782. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055888 (2022).","journal-title":"Circulation"},{"issue":"7","key":"12191_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.1780200714","volume":"20","author":"EC Keystone","year":"1977","unstructured":"Keystone, E. C. et al. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 20 (7), 1396\u20131401. https:\/\/doi.org\/10.1002\/art.1780200714 (1977).","journal-title":"Arthritis Rheum."},{"issue":"3","key":"12191_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/art.27304","volume":"62","author":"S Sacre","year":"2010","unstructured":"Sacre, S. et al. Fluoxetine and Citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum. 62 (3), 683\u2013693. https:\/\/doi.org\/10.1002\/art.27304 (2010).","journal-title":"Arthritis Rheum."},{"issue":"2","key":"12191_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2527\/1994.722404x","volume":"72","author":"DJ Smith","year":"1994","unstructured":"Smith, D. J. & Paulson, G. D. Growth characteristics of rats receiving ractopamine hydrochloride and the metabolic disposition of ractopamine hydrochloride after oral or intraperitoneal administration. J. Anim. Sci. 72 (2), 404\u2013414. https:\/\/doi.org\/10.2527\/1994.722404x (1994).","journal-title":"J. Anim. Sci."},{"issue":"2","key":"12191_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/jpet.110.176487","volume":"337","author":"L Piali","year":"2011","unstructured":"Piali, L. et al. The selective sphingosine 1-phosphate receptor 1 agonist Ponesimod protects against lymphocyte-mediated tissue inflammation. J. Pharmacol. Exp. Ther. 337 (2), 547\u2013556. https:\/\/doi.org\/10.1124\/jpet.110.176487 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"12191_CR19","doi-asserted-by":"publisher","unstructured":"Ly, T. T. G. et al. Inhibitory effect of etravirine, a Non-Nucleoside reverse transcriptase inhibitor, via anterior gradient protein 2 homolog degradation against ovarian Cancer metastasis. Int. J. Mol. Sci. 23 (2). https:\/\/doi.org\/10.3390\/ijms23020944 (2022).","DOI":"10.3390\/ijms23020944"},{"issue":"1","key":"12191_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","volume":"17","author":"MH Buch","year":"2021","unstructured":"Buch, M. H. et al. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat. Rev. Rheumatol. 17 (1), 17\u201333. https:\/\/doi.org\/10.1038\/s41584-020-00541-7 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"12191_CR21","doi-asserted-by":"publisher","first-page":"118907","DOI":"10.1016\/j.lfs.2020.118907","volume":"268","author":"J Gao","year":"2021","unstructured":"Gao, J. et al. The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis. Life Sci. 268, 118907. https:\/\/doi.org\/10.1016\/j.lfs.2020.118907 (2021).","journal-title":"Life Sci."},{"issue":"3","key":"12191_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","volume":"134","author":"G Hansen","year":"2008","unstructured":"Hansen, G. et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell. 134 (3), 496\u2013507. https:\/\/doi.org\/10.1016\/j.cell.2008.05.053 (2008).","journal-title":"Cell"},{"issue":"3","key":"12191_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1189\/jlb.71.3.511","volume":"71","author":"A Lehtonen","year":"2002","unstructured":"Lehtonen, A. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte\/macrophage differentiation. J. Leukoc. Biol. 71 (3), 511\u2013519. https:\/\/doi.org\/10.1189\/jlb.71.3.511 (2002).","journal-title":"J. Leukoc. Biol."},{"issue":"16","key":"12191_CR24","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1182\/blood-2009-08-235846","volume":"115","author":"M Perugini","year":"2010","unstructured":"Perugini, M. et al. Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood. 115 (16), 3346\u20133353. https:\/\/doi.org\/10.1182\/blood-2009-08-235846 (2010).","journal-title":"Blood"},{"issue":"3","key":"12191_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/all.15184","volume":"77","author":"N Ito","year":"2022","unstructured":"Ito, N. et al. The Ccl17 gene encoding TARC is synergistically transactivated by PU.1 and IRF4 driven by the mammalian common promoter in dendritic cells. Allergy. 77 (3), 1054\u20131059. https:\/\/doi.org\/10.1111\/all.15184 (2022).","journal-title":"Allergy"},{"issue":"1","key":"12191_CR26","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1152\/ajpgi.00267.2010","volume":"301","author":"SJ Koh","year":"2011","unstructured":"Koh, S. J. et al. Fluoxetine inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 301 (1), G9\u201319. https:\/\/doi.org\/10.1152\/ajpgi.00267.2010 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"12191_CR27","doi-asserted-by":"publisher","first-page":"577583","DOI":"10.1016\/j.jneuroim.2021.577583","volume":"356","author":"H Hou","year":"2021","unstructured":"Hou, H. et al. Ponesimod modulates the Th1\/Th17\/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 356, 577583. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577583 (2021).","journal-title":"J. Neuroimmunol."},{"key":"12191_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2016.07.016","volume":"94","author":"T Keranen","year":"2017","unstructured":"Keranen, T. et al. beta(2)-receptor agonists salbutamol and Terbutaline attenuated cytokine production by suppressing ERK pathway through cAMP in macrophages. Cytokine. 94, 1\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2016.07.016 (2017).","journal-title":"Cytokine"},{"issue":"8","key":"12191_CR29","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.4049\/jimmunol.2000004","volume":"205","author":"I Piseddu","year":"2020","unstructured":"Piseddu, I. et al. Constitutive expression of CCL22 is mediated by T Cell-Derived GM-CSF. J. Immunol. (Baltimore Md. : 1950). 205 (8), 2056\u20132065. https:\/\/doi.org\/10.4049\/jimmunol.2000004 (2020).","journal-title":"J. Immunol. (Baltimore Md. : 1950)"},{"issue":"9","key":"12191_CR30","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1007\/s00432-023-04638-w","volume":"149","author":"A Vattai","year":"2023","unstructured":"Vattai, A. et al. Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia. J. Cancer Res. Clin. Oncol. 149 (9), 6613\u20136623. https:\/\/doi.org\/10.1007\/s00432-023-04638-w (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"12191_CR31","doi-asserted-by":"publisher","first-page":"110719","DOI":"10.1016\/j.celrep.2022.110719","volume":"39","author":"MC Lee","year":"2022","unstructured":"Lee, M. C. Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization. Cell. Rep. 39 (3), 110719. https:\/\/doi.org\/10.1016\/j.celrep.2022.110719 (2022).","journal-title":"Cell. Rep."},{"key":"12191_CR32","doi-asserted-by":"publisher","unstructured":"Arnold, I. C. et al. The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses. J. Exp. Med. 217 (12). https:\/\/doi.org\/10.1084\/jem.20190706 (2020).","DOI":"10.1084\/jem.20190706"},{"issue":"35","key":"12191_CR33","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.1073\/pnas.1506254112","volume":"112","author":"M Weiss","year":"2015","unstructured":"Weiss, M. et al. IRF5 controls both acute and chronic inflammation. Proc. Natl. Acad. Sci. U. S. A. 112 (35), 11001\u201311006. https:\/\/doi.org\/10.1073\/pnas.1506254112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"12191_CR34","doi-asserted-by":"publisher","unstructured":"Silva, J. R. et al. Skin-resident dendritic cells mediate postoperative pain via CCR4 on sensory neurons. Proc. Natl. Acad. Sci. U. S. A. 119 (4). https:\/\/doi.org\/10.1073\/pnas.2118238119 (2022).","DOI":"10.1073\/pnas.2118238119"},{"issue":"3","key":"12191_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.it.2017.12.003","volume":"39","author":"AD Cook","year":"2018","unstructured":"Cook, A. D. et al. Immune cytokines and their receptors in inflammatory pain. Trends Immunol. 39 (3), 240\u2013255. https:\/\/doi.org\/10.1016\/j.it.2017.12.003 (2018).","journal-title":"Trends Immunol."},{"key":"12191_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbi.2023.04.011","volume":"111","author":"R Hou","year":"2023","unstructured":"Hou, R. et al. The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts. Brain Behav. Immun. 111, 249\u2013258. https:\/\/doi.org\/10.1016\/j.bbi.2023.04.011 (2023).","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"12191_CR37","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s11033-022-08219-x","volume":"50","author":"H Mojiri-Forushani","year":"2023","unstructured":"Mojiri-Forushani, H. et al. Inhibitory effects of fluoxetine on the secretion of inflammatory mediators and JAK\/STAT3 and JNK\/TLR4 gene expression. Mol. Biol. Rep. 50 (3), 2231\u20132241. https:\/\/doi.org\/10.1007\/s11033-022-08219-x (2023).","journal-title":"Mol. Biol. Rep."},{"key":"12191_CR38","doi-asserted-by":"publisher","first-page":"111437","DOI":"10.1016\/j.biopha.2021.111437","volume":"138","author":"JF Creeden","year":"2021","unstructured":"Creeden, J. F. et al. Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection. Biomed. Pharmacother. 138, 111437. https:\/\/doi.org\/10.1016\/j.biopha.2021.111437 (2021).","journal-title":"Biomed. Pharmacother"},{"issue":"suppl_4","key":"12191_CR39","doi-asserted-by":"publisher","first-page":"piv43","DOI":"10.1093\/rheumatology\/kex419","volume":"57","author":"K Fu","year":"2018","unstructured":"Fu, K. et al. Osteoarthritis: the genesis of pain. Rheumatol. (Oxford). 57 (suppl_4), piv43\u2013iv50. https:\/\/doi.org\/10.1093\/rheumatology\/kex419 (2018).","journal-title":"Rheumatol. (Oxford)"},{"issue":"5","key":"12191_CR40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","volume":"16","author":"HG Schaible","year":"2014","unstructured":"Schaible, H. G. Nociceptive neurons detect cytokines in arthritis. Arthritis Res. Ther. 16 (5), 470. https:\/\/doi.org\/10.1186\/s13075-014-0470-8 (2014).","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"12191_CR41","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.pnpbp.2009.08.013","volume":"33","author":"YL Luo","year":"2009","unstructured":"Luo, Y. L. et al. A randomized double-blind clinical trial on analgesic efficacy of Fluoxetine for persistent somatoform pain disorder. Prog Neuropsychopharmacol. Biol. Psychiatry. 33 (8), 1522\u20131525. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.08.013 (2009).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"12191_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pnpbp.2012.06.003","volume":"39","author":"D Johansson","year":"2012","unstructured":"Johansson, D. et al. Celecoxib enhances the effect of reboxetine and Fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol. Biol. Psychiatry. 39 (1), 143\u2013148. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.003 (2012).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"12191_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.tvjl.2003.10.020","volume":"167","author":"MN Sillence","year":"2004","unstructured":"Sillence, M. N. Technologies for the control of fat and lean deposition in livestock. Vet. J. 167 (3), 242\u2013257. https:\/\/doi.org\/10.1016\/j.tvjl.2003.10.020 (2004).","journal-title":"Vet. J."},{"issue":"5","key":"12191_CR44","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1096\/fj.11-201640","volume":"26","author":"M Bosmann","year":"2012","unstructured":"Bosmann, M. et al. Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury. FASEB J. 26 (5), 2137\u20132144. https:\/\/doi.org\/10.1096\/fj.11-201640 (2012).","journal-title":"FASEB J."},{"key":"12191_CR45","doi-asserted-by":"publisher","first-page":"109948","DOI":"10.1016\/j.cellsig.2021.109948","volume":"82","author":"R Sohn","year":"2021","unstructured":"Sohn, R. et al. Adrenergic signalling in osteoarthritis. Cell. Signal. 82, 109948. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109948 (2021).","journal-title":"Cell. Signal."},{"key":"12191_CR46","doi-asserted-by":"publisher","first-page":"24548","DOI":"10.1038\/srep24548","volume":"6","author":"H Wu","year":"2016","unstructured":"Wu, H. et al. beta2-adrenoceptor signaling reduction in dendritic cells is involved in the inflammatory response in adjuvant-induced arthritic rats. Sci. Rep. 6, 24548. https:\/\/doi.org\/10.1038\/srep24548 (2016).","journal-title":"Sci. Rep."},{"key":"12191_CR47","doi-asserted-by":"publisher","first-page":"866097","DOI":"10.3389\/fimmu.2022.866097","volume":"13","author":"ESA Pacini","year":"2022","unstructured":"Pacini, E. S. A. et al. Extracellular cAMP-Adenosine pathway signaling: A potential therapeutic target in chronic inflammatory airway diseases. Front. Immunol. 13, 866097. https:\/\/doi.org\/10.3389\/fimmu.2022.866097 (2022).","journal-title":"Front. Immunol."},{"issue":"7","key":"12191_CR48","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.175.7.4697","volume":"175","author":"V von Bulow","year":"2005","unstructured":"von Bulow, V. et al. Zinc-mediated Inhibition of Cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of Guanosine 3\u2019,5\u2019-cyclic monophosphate. J. Immunol. (Baltimore Md. : 1950). 175 (7), 4697\u20134705. https:\/\/doi.org\/10.4049\/jimmunol.175.7.4697 (2005).","journal-title":"J. Immunol. (Baltimore Md. : 1950)"},{"issue":"2","key":"12191_CR49","doi-asserted-by":"publisher","first-page":"e0148144","DOI":"10.1371\/journal.pone.0148144","volume":"11","author":"T Keranen","year":"2016","unstructured":"Keranen, T. et al. Anti-Inflammatory effects of beta2-Receptor agonists salbutamol and Terbutaline are mediated by MKP-1. PLoS One. 11 (2), e0148144. https:\/\/doi.org\/10.1371\/journal.pone.0148144 (2016).","journal-title":"PLoS One"},{"issue":"7","key":"12191_CR50","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/bph.12189","volume":"169","author":"R Korhonen","year":"2013","unstructured":"Korhonen, R. et al. Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br. J. Pharmacol. 169 (7), 1525\u20131536. https:\/\/doi.org\/10.1111\/bph.12189 (2013).","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"12191_CR51","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.molimm.2009.03.018","volume":"46","author":"XF Qi","year":"2009","unstructured":"Qi, X. F. et al. The adenylyl cyclase-cAMP system suppresses TARC\/CCL17 and MDC\/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes. Mol. Immunol. 46 (10), 1925\u20131934. https:\/\/doi.org\/10.1016\/j.molimm.2009.03.018 (2009).","journal-title":"Mol. Immunol."},{"key":"12191_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010818-021358","volume":"59","author":"J Chun","year":"2019","unstructured":"Chun, J. et al. Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders. Annu. Rev. Pharmacol. Toxicol. 59, 149\u2013170. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021358 (2019).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"15","key":"12191_CR53","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1182\/blood-2009-04-217620","volume":"114","author":"M Ishii","year":"2009","unstructured":"Ishii, M. et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 114 (15), 3244\u20133254. https:\/\/doi.org\/10.1182\/blood-2009-04-217620 (2009).","journal-title":"Blood"},{"issue":"2","key":"12191_CR54","doi-asserted-by":"publisher","first-page":"e22132","DOI":"10.1096\/fj.202101531R","volume":"36","author":"Y Kihara","year":"2022","unstructured":"Kihara, Y. et al. Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P(1) -selective modulation. FASEB J. 36 (2), e22132. https:\/\/doi.org\/10.1096\/fj.202101531R (2022).","journal-title":"FASEB J."},{"issue":"1","key":"12191_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/03009742.2016.1158311","volume":"46","author":"MR Hillen","year":"2017","unstructured":"Hillen, M. R. et al. Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis. Scand. J. Rheumatol. 46 (1), 11\u201316. https:\/\/doi.org\/10.3109\/03009742.2016.1158311 (2017).","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"12191_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/ard.2003.017566","volume":"64","author":"TR Radstake","year":"2005","unstructured":"Radstake, T. R. et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann. Rheum. Dis. 64 (3), 359\u2013367. https:\/\/doi.org\/10.1136\/ard.2003.017566 (2005).","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"12191_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/14787210.6.4.427","volume":"6","author":"E Seminari","year":"2008","unstructured":"Seminari, E. et al. Etravirine for the treatment of HIV infection. Expert Rev. Anti Infect. Ther. 6 (4), 427\u2013433. https:\/\/doi.org\/10.1586\/14787210.6.4.427 (2008).","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"12191_CR58","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/jcb.25169","volume":"116","author":"V Esposito","year":"2015","unstructured":"Esposito, V. et al. Different impact of antiretroviral drugs on bone differentiation in an in vitro model. J. Cell. Biochem. 116 (10), 2188\u20132194. https:\/\/doi.org\/10.1002\/jcb.25169 (2015).","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"12191_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41419-018-0332-4","volume":"9","author":"A Achuthan","year":"2018","unstructured":"Achuthan, A. et al. Glucocorticoids promote apoptosis of Proinflammatory monocytes by inhibiting ERK activity. Cell. Death Dis. 9 (3), 267. https:\/\/doi.org\/10.1038\/s41419-018-0332-4 (2018).","journal-title":"Cell. Death Dis."},{"key":"12191_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molimm.2024.01.008","volume":"166","author":"T Hourani","year":"2024","unstructured":"Hourani, T. et al. Signaling pathways underlying TGF-beta mediated suppression of IL-12A gene expression in monocytes. Mol. Immunol. 166, 101\u2013109. https:\/\/doi.org\/10.1016\/j.molimm.2024.01.008 (2024).","journal-title":"Mol. Immunol."},{"issue":"1","key":"12191_CR61","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/s41598-024-53519-w","volume":"14","author":"DVL Romero","year":"2024","unstructured":"Romero, D. V. L. et al. Epigenetic and transcriptional regulation of cytokine production by plasmodium falciparum-exposed monocytes. Sci. Rep. 14 (1), 2949. https:\/\/doi.org\/10.1038\/s41598-024-53519-w (2024).","journal-title":"Sci. Rep."},{"key":"12191_CR62","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2014.00346","volume":"5","author":"CL Lubahn","year":"2014","unstructured":"Lubahn, C. L. et al. Targeting alpha- and beta-Adrenergic receptors differentially shifts Th1, Th2, and inflammatory cytokine profiles in immune organs to attenuate adjuvant arthritis. Front. Immunol. 5, 346. https:\/\/doi.org\/10.3389\/fimmu.2014.00346 (2014).","journal-title":"Front. Immunol."},{"issue":"1","key":"12191_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-020-02212-0","volume":"22","author":"KM Lee","year":"2020","unstructured":"Lee, K. M. et al. IL-23 in arthritic and inflammatory pain development in mice. Arthritis Res. Ther. 22 (1), 123. https:\/\/doi.org\/10.1186\/s13075-020-02212-0 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"12191_CR64","doi-asserted-by":"publisher","unstructured":"Cook, A. D. et al. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17. JCI Insight. 3 (6). https:\/\/doi.org\/10.1172\/jci.insight.99249 (2018).","DOI":"10.1172\/jci.insight.99249"},{"key":"12191_CR65","doi-asserted-by":"publisher","unstructured":"Lee, K. M. et al. CCL17 in inflammation and pain. J. Immunol. (Baltimore, Md.: 2020). 205(1), 213\u2013222. https:\/\/doi.org\/10.4049\/jimmunol.2000315 (1950).","DOI":"10.4049\/jimmunol.2000315"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12191-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12191-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12191-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:18:09Z","timestamp":1753258689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12191-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12191-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26734"}}